PDB Short entry for 3L8V HEADER TRANSFERASE 04-JAN-10 3L8V TITLE CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE TITLE 2 GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED TITLE 3 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TYROSINE KINASE DOMAIN, UNP RESIDUES 1049-1360; COMPND 5 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF RECEPTOR, HGF/SF COMPND 6 RECEPTOR, MET PROTO-ONCOGENE TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PACHLT-A KEYWDS RECEPTOR TYROSINE KINASE, SIGNAL TRANSDUCTION, GRB2, SHC, ATP- KEYWDS 2 BINDING, GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, KEYWDS 3 PROTO-ONCOGENE, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, KEYWDS 4 ALTERNATIVE SPLICING, CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, KEYWDS 5 KINASE, POLYMORPHISM, RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR J.SACK REVDAT 4 06-SEP-23 3L8V 1 REMARK REVDAT 3 13-OCT-21 3L8V 1 REMARK SEQADV REVDAT 2 14-MAR-18 3L8V 1 KEYWDS REVDAT 1 05-MAY-10 3L8V 0 JRNL AUTH D.K.WILLIAMS,X.T.CHEN,C.TARBY,R.KALTENBACH,Z.W.CAI, JRNL AUTH 2 J.S.TOKARSKI,Y.AN,J.S.SACK,B.WAUTLET,J.GULLO-BROWN, JRNL AUTH 3 B.J.HENLEY,R.JEYASEELAN,K.KELLAR,V.MANNE,G.L.TRAINOR, JRNL AUTH 4 L.J.LOMBARDO,J.FARGNOLI,R.M.BORZILLERI JRNL TITL DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF JRNL TITL 2 NOVEL BIARYLAMINE-BASED MET KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 2998 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20382527 JRNL DOI 10.1016/J.BMCL.2010.01.042 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12391 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1003 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2389 REMARK 3 BIN R VALUE (WORKING SET) : 0.1799 REMARK 3 BIN FREE R VALUE : 0.2455 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.47 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 221 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2323 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.45690 REMARK 3 B22 (A**2) : 2.60230 REMARK 3 B33 (A**2) : -2.14540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.267 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3L8V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1000056979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12397 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 47.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.11100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3C1X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.25000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.25000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1047 REMARK 465 ALA A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 LEU A 1225 REMARK 465 ALA A 1226 REMARK 465 ARG A 1227 REMARK 465 ASP A 1228 REMARK 465 MET A 1229 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 PHE A 1234 REMARK 465 ASP A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A1058 -85.96 -71.15 REMARK 500 ASN A1059 120.27 176.05 REMARK 500 ILE A1084 64.30 -101.28 REMARK 500 HIS A1088 -112.78 -135.97 REMARK 500 PHE A1089 43.27 -94.75 REMARK 500 ASN A1100 -72.92 48.83 REMARK 500 SER A1111 -155.48 -132.46 REMARK 500 LEU A1112 127.87 73.98 REMARK 500 ASN A1113 96.46 107.62 REMARK 500 ARG A1114 87.23 175.00 REMARK 500 ILE A1115 -62.36 -106.83 REMARK 500 ASP A1117 -55.76 -9.22 REMARK 500 ILE A1118 -5.40 -161.20 REMARK 500 GLU A1150 -80.76 -96.80 REMARK 500 ARG A1203 -23.22 82.78 REMARK 500 ASP A1204 46.20 -140.98 REMARK 500 LYS A1244 -4.28 -164.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L8V A 1 DBREF 3L8V A 1049 1360 UNP P08581 MET_HUMAN 1049 1360 SEQADV 3L8V GLY A 1047 UNP P08581 EXPRESSION TAG SEQADV 3L8V ALA A 1048 UNP P08581 EXPRESSION TAG SEQADV 3L8V PHE A 1194 UNP P08581 TYR 1194 ENGINEERED MUTATION SEQADV 3L8V PHE A 1234 UNP P08581 TYR 1234 ENGINEERED MUTATION SEQADV 3L8V ASP A 1235 UNP P08581 TYR 1235 ENGINEERED MUTATION SEQRES 1 A 314 GLY ALA ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN SEQRES 2 A 314 PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY SEQRES 3 A 314 PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY SEQRES 4 A 314 ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU SEQRES 5 A 314 ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER SEQRES 6 A 314 LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE SEQRES 7 A 314 LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO SEQRES 8 A 314 ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU SEQRES 9 A 314 GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY SEQRES 10 A 314 ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO SEQRES 11 A 314 THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA SEQRES 12 A 314 LYS GLY MET LYS PHE LEU ALA SER LYS LYS PHE VAL HIS SEQRES 13 A 314 ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS SEQRES 14 A 314 PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 15 A 314 MET TYR ASP LYS GLU PHE ASP SER VAL HIS ASN LYS THR SEQRES 16 A 314 GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER SEQRES 17 A 314 LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SEQRES 18 A 314 SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY SEQRES 19 A 314 ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR SEQRES 20 A 314 VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU SEQRES 21 A 314 TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS SEQRES 22 A 314 TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU SEQRES 23 A 314 LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE SEQRES 24 A 314 GLY GLU HIS TYR VAL HIS VAL ASN ALA THR TYR VAL ASN SEQRES 25 A 314 VAL LYS HET L8V A 1 33 HETNAM L8V 2-({4-[(2-AMINOPYRIDIN-4-YL)OXY]-3-FLUOROPHENYL}AMINO)- HETNAM 2 L8V N-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE FORMUL 2 L8V C23 H16 F3 N5 O2 FORMUL 3 HOH *100(H2 O) HELIX 1 1 ASP A 1054 LEU A 1058 5 5 HELIX 2 2 ASN A 1059 HIS A 1068 1 10 HELIX 3 3 ILE A 1118 ILE A 1130 1 13 HELIX 4 4 ASP A 1164 ASN A 1171 1 8 HELIX 5 5 THR A 1177 LYS A 1198 1 22 HELIX 6 6 ALA A 1206 ARG A 1208 5 3 HELIX 7 7 PRO A 1246 MET A 1250 5 5 HELIX 8 8 ALA A 1251 THR A 1257 1 7 HELIX 9 9 THR A 1261 THR A 1278 1 18 HELIX 10 10 ASN A 1288 PHE A 1290 5 3 HELIX 11 11 ASP A 1291 GLN A 1298 1 8 HELIX 12 12 PRO A 1309 TRP A 1320 1 12 HELIX 13 13 LYS A 1323 ARG A 1327 5 5 HELIX 14 14 SER A 1329 THR A 1343 1 15 SHEET 1 A 6 VAL A1070 ILE A1071 0 SHEET 2 A 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 A 6 LEU A1154 PRO A1158 -1 O LEU A1154 N CYS A1146 SHEET 4 A 6 LYS A1103 LYS A1110 -1 N ALA A1108 O LEU A1157 SHEET 5 A 6 VAL A1092 ASP A1099 -1 N TYR A1093 O VAL A1109 SHEET 6 A 6 LEU A1076 VAL A1083 -1 N ILE A1077 O THR A1096 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 CISPEP 1 LEU A 1112 ASN A 1113 0 0.43 CISPEP 2 ASN A 1113 ARG A 1114 0 -2.38 SITE 1 AC1 19 ILE A1084 VAL A1092 ALA A1108 LYS A1110 SITE 2 AC1 19 GLU A1127 MET A1131 PHE A1134 VAL A1155 SITE 3 AC1 19 LEU A1157 PRO A1158 TYR A1159 MET A1160 SITE 4 AC1 19 LEU A1195 HIS A1202 MET A1211 VAL A1220 SITE 5 AC1 19 ALA A1221 ASP A1222 PHE A1223 CRYST1 42.800 47.250 154.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023364 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021164 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006472 0.00000